References
- Berg M J, Berlinger W G, Goldberg M J, Spector R, Johnson G F. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med 1982; 307: 642–644
- Neuvonen P J, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol 1980; 17: 51–57
- Pond S M, Olson K R, Osterloh J D, Tong T G. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA 1984; 251: 3104–3108
- Oellerich M. Enzyme immunoassays in clinical chemistry: Present status and trends. J Clin Chem Clin Biochem 1980; 18: 197–208
- Oellerich M, Kulpmann W R, Haeckel R, Heyer R. Determination of phenobarbital and phenytoin in serum by a mechanized enzyme immunoassay (EMIT) in comparison with a gas-liquid chromatographic method. J Clin Chem Clin Biochem 1977; 15: 353–358
- Levy G. Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med 1982; 307: 676–678
- Park G D, Goldberg M J, Spector R, et al. The effects of activated charcoal on digoxin and digitoxin clearance. Drug Intell Clin Pharmacol 1985; 19: 937–941
- Mahutte C K, True R J, Michiels T M, Berman J M, Light R W. Increased serum theophylline clearance with orally administered activated charcoal. Am Rev Respir Dis 1983; 128: 820–822